Navigation Links
PhUSE Annual Conference to focus on Patient Centricity
Date:3/14/2013

Brussels, Belgium (PRWEB) March 14, 2013

PhUSE presents the 2013 Annual PhUSE conference. The conference, which will take place in Brussels, Belgium, will turn the spotlight onto ‘Patient Centricity’ in the pharmaceutical world. The conference will address the relationship between the data that drives clinical research and the patients to whom the industry seeks to provide novel therapies, putting patients at the heart of the discussion.

PhUSE is pleased to announce that the keynote speaker at the Annual PhUSE conference will be Doctor Ben Goldacre, science journalist and author of “Bad Pharma.”

"PhUSE has a rich history of excellent keynote presenters and securing Dr. Ben Goldacre just adds to the impressive list of industry influencers. His mix of journalistic skills together with a deep understanding of medicine, the industry and clinical data will give an insight into the challenges that we face as we come to terms with Patent Centricity" says Stephen Bamford, Events Director for PhUSE and Executive Director and co-founder at Cerafor.

The conference will also include workshops focusing on indications, diseases, and data analysis. Through discussion groups, conference attendees will learn and contribute to a better understanding of how to further improve standardization in therapeutic areas, leading to better outcomes for patients. Specifically, Oncology and Rheumatoid Arthritis will be discussed in Therapeutic Area Discussion Clubs.

PhUSE provides a forum second to none for networking and sharing knowledge with colleagues. Attendees at the annual conference will benefit from over 100 presentations centered around the PhUSE topic streams, with 14 different streams, including Management, CDISC and Statistics & PK.

Registration is open. Call for papers is open. Sponsorship opportunities are available.

PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and eClinical IT professionals.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10400466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
2. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
3. Presidential Recognition Awards presented during the 2012 AIUM Annual Convention
4. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
5. ASCO releases studies from upcoming annual meeting
6. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
7. Mayo Clinic urologists present findings at American Urological Association Annual Meeting
8. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
9. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
10. Los Robles Hospital’s Annual Health Fair Attended by Khanna Institute
11. NOVAtime Solutions to be showcased at Booth #1821 in the upcoming Society for Human Resource Management (SHRM) Annual Conference and Exposition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... ... , ... Guide to FDA and EU Medical Device Regulations: 2017 Edition, **An ... the Atlantic devicemakers do business, this fully updated and expanded guide keeps them in ... the full text of the FDA’s regulations in 21 CFR Parts 800 to 898, ...
(Date:6/28/2017)... ... ... control has seen the never-ending twists on the house flipping show genre. The shows promote ... But what about the buyers of the flipper's flip. , Here is an ... An email recently sent to Gary Case said, “Just closed on a home on Capitol ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold & ... for the Illinois State Bar Association , in accordance with the organization’s rules of ... following a state-wide election and served in that capacity for the past year prior to ...
(Date:6/28/2017)... , ... June 28, 2017 , ... American Farmer proudly ... episode of the award winning television series, scheduled to broadcast fourth quarter 2017. American ... originated as a regional supplier of garden pea seed. As demand grew, the small ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
(Date:5/23/2017)... 2017  Leaf Healthcare, recognized for developing one ... pressure ulcer prevention, will unveil its comprehensive mobility ... Care Nurses, National Teaching Institute and Critical Care ... Leaf Patient Monitoring System is the first mobility ... The system seamlessly tracks patient movement throughout the ...
Breaking Medicine Technology: